Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Nov;92(5):2262–2273. doi: 10.1172/JCI116830

High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.

K J Lackner 1, H Dieplinger 1, G Nowicka 1, G Schmitz 1
PMCID: PMC288407  PMID: 7693760

Abstract

A 7-yr-old girl with high density lipoprotein (HDL) deficiency and xanthomas has been identified in a Turkish kindred with repetitive consanguinity. She has severely reduced HDL-cholesterol and no apolipoprotein (apo) A-I. ApoA-II is reduced, whereas apoA-IV and apoC-III are normal. ApoB and low density lipoprotein (LDL)-cholesterol are increased. This is reflected in hypercholesterolemia. VLDL and IDL particles are low, and serum triglycerides are normal. The genetic defect could be identified as a base insertion into the third exon of the apoA-I gene. This leads to a nonsense peptide sequence beginning at amino acid 5 of the mature plasma protein and early termination of translation. The patient is homozygous for this mutation. Pedigree analysis indicated an autosomal dominant inheritance with no evidence of another genetic defect of lipoprotein metabolism in the kindred. In HDL deficiency, HDL binding to leukocytes was increased compared to normal. In the postprandial state, binding of labeled HDL3 to leukocytes is unchanged. This is in contrast to results with postprandially isolated leukocytes from controls or Tangier patients, which have a reduced binding capacity for HDL3. These results indicate that postprandial HDL precursors may compete the binding of labeled HDL3. The metabolic consequences of HDL deficiency were analyzed. There is only a small number of HDL-like particles containing apoA-II, apoA-IV, apoE, and lecithin/cholesteryl acyl transferase. The C-apolipoproteins were normal in the proband. Due to the lack of HDL they can only associate with apoB-containing particles, where they may interfere with cellular uptake. Thus, pure apoA-I deficiency leads to a complex metabolic derangement.

Full text

PDF
2262

Images in this article

2265Image
on p.2265
2265Image
on p.2265
2265Image
on p.2265
2266Image
on p.2266
2266Image
on p.2266
2266Image
on p.2266

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antonarakis S. E., Oettgen P., Chakravarti A., Halloran S. L., Hudson R. R., Feisee L., Karathanasis S. K. DNA polymorphism haplotypes of the human apolipoprotein APOA1-APOC3-APOA4 gene cluster. Hum Genet. 1988 Nov;80(3):265–273. doi: 10.1007/BF01790095. [DOI] [PubMed] [Google Scholar]
  2. Badimon J. J., Badimon L., Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest. 1990 Apr;85(4):1234–1241. doi: 10.1172/JCI114558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Badimon J. J., Badimon L., Galvez A., Dische R., Fuster V. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab Invest. 1989 Mar;60(3):455–461. [PubMed] [Google Scholar]
  4. Bisgaier C. L., Glickman R. M. Intestinal synthesis, secretion, and transport of lipoproteins. Annu Rev Physiol. 1983;45:625–636. doi: 10.1146/annurev.ph.45.030183.003205. [DOI] [PubMed] [Google Scholar]
  5. Brown M. L., Inazu A., Hesler C. B., Agellon L. B., Mann C., Whitlock M. E., Marcel Y. L., Milne R. W., Koizumi J., Mabuchi H. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature. 1989 Nov 23;342(6248):448–451. doi: 10.1038/342448a0. [DOI] [PubMed] [Google Scholar]
  6. Brown M. S., Goldstein J. L. Receptor-mediated endocytosis: insights from the lipoprotein receptor system. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3330–3337. doi: 10.1073/pnas.76.7.3330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Castelli W. P., Garrison R. J., Wilson P. W., Abbott R. D., Kalousdian S., Kannel W. B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986 Nov 28;256(20):2835–2838. [PubMed] [Google Scholar]
  8. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  9. Clay M. A., Rye K. A., Barter P. J. Evidence in vitro that hepatic lipase reduces the concentration of apolipoprotein A-I in rabbit high-density lipoproteins. Biochim Biophys Acta. 1990 May 1;1044(1):50–56. doi: 10.1016/0005-2760(90)90217-l. [DOI] [PubMed] [Google Scholar]
  10. De Bruin T. W., Brouwer C. B., Gimpel J. A., Erkelens D. W. Postprandial decrease in HDL cholesterol and HDL apo A-I in normal subjects in relation to triglyceride metabolism. Am J Physiol. 1991 Mar;260(3 Pt 1):E492–E498. doi: 10.1152/ajpendo.1991.260.3.E492. [DOI] [PubMed] [Google Scholar]
  11. Deeb S. S., Takata K., Peng R. L., Kajiyama G., Albers J. J. A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. Am J Hum Genet. 1990 Apr;46(4):822–827. [PMC free article] [PubMed] [Google Scholar]
  12. Dieplinger H., Lobentanz E. M., König P., Graf H., Sandholzer C., Matthys E., Rosseneu M., Utermann G. Plasma apolipoprotein A-IV metabolism in patients with chronic renal disease. Eur J Clin Invest. 1992 Mar;22(3):166–174. doi: 10.1111/j.1365-2362.1992.tb01822.x. [DOI] [PubMed] [Google Scholar]
  13. Frischauf A. M., Lehrach H., Poustka A., Murray N. Lambda replacement vectors carrying polylinker sequences. J Mol Biol. 1983 Nov 15;170(4):827–842. doi: 10.1016/s0022-2836(83)80190-9. [DOI] [PubMed] [Google Scholar]
  14. Funke H., von Eckardstein A., Pritchard P. H., Karas M., Albers J. J., Assmann G. A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities. J Clin Invest. 1991 Jan;87(1):371–376. doi: 10.1172/JCI114997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Goldberg I. J., Blaner W. S., Vanni T. M., Moukides M., Ramakrishnan R. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J Clin Invest. 1990 Aug;86(2):463–473. doi: 10.1172/JCI114732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gordon J. I., Budelier K. A., Sims H. F., Edelstein C., Scanu A. M., Strauss A. W. Biosynthesis of human preproapolipoprotein A-II. J Biol Chem. 1983 Nov 25;258(22):14054–14059. [PubMed] [Google Scholar]
  17. Gordon J. I., Sims H. F., Lentz S. R., Edelstein C., Scanu A. M., Strauss A. W. Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier's disease. J Biol Chem. 1983 Mar 25;258(6):4037–4044. [PubMed] [Google Scholar]
  18. Gustafson A., McConathy W. J., Alaupovic P., Curry M. D., Persson B. Identification of lipoprotein families in a variant of human plasma apolipoprotein A deficiency. Scand J Clin Lab Invest. 1979 Jun;39(4):377–387. doi: 10.3109/00365517909106122. [DOI] [PubMed] [Google Scholar]
  19. Hiasa Y., Maeda T., Mori H. Deficiency of apolipoproteins A-I and C-III and severe coronary heart disease. Clin Cardiol. 1986 Jul;9(7):349–352. doi: 10.1002/clc.4960090709. [DOI] [PubMed] [Google Scholar]
  20. Ito Y., Azrolan N., O'Connell A., Walsh A., Breslow J. L. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science. 1990 Aug 17;249(4970):790–793. doi: 10.1126/science.2167514. [DOI] [PubMed] [Google Scholar]
  21. Jeenah M., Kessling A., Miller N., Humphries S. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med. 1990 Jun;7(3):233–241. [PubMed] [Google Scholar]
  22. Johnson W. J., Mahlberg F. H., Rothblat G. H., Phillips M. C. Cholesterol transport between cells and high-density lipoproteins. Biochim Biophys Acta. 1991 Oct 1;1085(3):273–298. doi: 10.1016/0005-2760(91)90132-2. [DOI] [PubMed] [Google Scholar]
  23. Karathanasis S. K. Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6374–6378. doi: 10.1073/pnas.82.19.6374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Karathanasis S. K., Ferris E., Haddad I. A. DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7198–7202. doi: 10.1073/pnas.84.20.7198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Karathanasis S. K., Zannis V. I., Breslow J. L. Isolation and characterization of the human apolipoprotein A-I gene. Proc Natl Acad Sci U S A. 1983 Oct;80(20):6147–6151. doi: 10.1073/pnas.80.20.6147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kidd V. J., Wallace R. B., Itakura K., Woo S. L. alpha 1-antitrypsin deficiency detection by direct analysis of the mutation in the gene. Nature. 1983 Jul 21;304(5923):230–234. doi: 10.1038/304230a0. [DOI] [PubMed] [Google Scholar]
  27. Lackner K. J., Law S. W., Brewer H. B., Jr, Sakaguchi A. Y., Naylor S. L. The human apolipoprotein A-II gene is located on chromosome 1. Biochem Biophys Res Commun. 1984 Aug 16;122(3):877–883. doi: 10.1016/0006-291x(84)91172-0. [DOI] [PubMed] [Google Scholar]
  28. Lackner K. J., Law S. W., Brewer H. B., Jr The human apolipoprotein A-II gene: complete nucleic acid sequence and genomic organization. Nucleic Acids Res. 1985 Jun 25;13(12):4597–4608. doi: 10.1093/nar/13.12.4597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Law S. W., Brewer H. B., Jr Nucleotide sequence and the encoded amino acids of human apolipoprotein A-I mRNA. Proc Natl Acad Sci U S A. 1984 Jan;81(1):66–70. doi: 10.1073/pnas.81.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mahley R. W., Innerarity T. L., Rall S. C., Jr, Weisgraber K. H. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. 1984 Dec 1;25(12):1277–1294. [PubMed] [Google Scholar]
  31. Marsh J. B. Apoproteins of the lipoproteins in a nonrecirculating perfusate of rat liver. J Lipid Res. 1976 Jan;17(1):85–89. [PubMed] [Google Scholar]
  32. Matsunaga T., Hiasa Y., Yanagi H., Maeda T., Hattori N., Yamakawa K., Yamanouchi Y., Tanaka I., Obara T., Hamaguchi H. Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2793–2797. doi: 10.1073/pnas.88.7.2793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Middleton-Price H. R., van den Berghe J. A., Scott J., Knott T. J., Malcolm S. Regional chromosomal localisation of APOA2 to 1q21-1q23. Hum Genet. 1988 Jul;79(3):283–285. doi: 10.1007/BF00366253. [DOI] [PubMed] [Google Scholar]
  34. Norum R. A., Lakier J. B., Goldstein S., Angel A., Goldberg R. B., Block W. D., Noffze D. K., Dolphin P. J., Edelglass J., Bogorad D. D. Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med. 1982 Jun 24;306(25):1513–1519. doi: 10.1056/NEJM198206243062503. [DOI] [PubMed] [Google Scholar]
  35. Nowicka G., Brüning T., Böttcher A., Kahl G., Schmitz G. Macrophage interaction of HDL subclasses separated by free flow isotachophoresis. J Lipid Res. 1990 Nov;31(11):1947–1963. [PubMed] [Google Scholar]
  36. Nowicka G., Brüning T., Grothaus B., Kahl G., Schmitz G. Characterization of apolipoprotein B-containing lipoproteins separated by preparative free flow isotachophoresis. J Lipid Res. 1990 Jul;31(7):1173–1186. [PubMed] [Google Scholar]
  37. Ordovas J. M., Cassidy D. K., Civeira F., Bisgaier C. L., Schaefer E. J. Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. J Biol Chem. 1989 Oct 5;264(28):16339–16342. [PubMed] [Google Scholar]
  38. Rubin E. M., Krauss R. M., Spangler E. A., Verstuyft J. G., Clift S. M. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 1991 Sep 19;353(6341):265–267. doi: 10.1038/353265a0. [DOI] [PubMed] [Google Scholar]
  39. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Schaefer E. J., Heaton W. H., Wetzel M. G., Brewer H. B., Jr Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis. 1982 Jan-Feb;2(1):16–26. doi: 10.1161/01.atv.2.1.16. [DOI] [PubMed] [Google Scholar]
  41. Schmitz G., Assmann G., Brennhausen B., Schaefer H. J. Interaction of Tangier lipoproteins with cholesteryl ester-laden mouse peritoneal macrophages. J Lipid Res. 1987 Jan;28(1):87–99. [PubMed] [Google Scholar]
  42. Schmitz G., Brüning T., Kovacs E., Barlage S. Fluorescence flow cytometry of human leukocytes in the detection of LDL receptor defects in the differential diagnosis of hypercholesterolemia. Arterioscler Thromb. 1993 Jul;13(7):1053–1065. doi: 10.1161/01.atv.13.7.1053. [DOI] [PubMed] [Google Scholar]
  43. Schmitz G., Niemann R., Brennhausen B., Krause R., Assmann G. Regulation of high density lipoprotein receptors in cultured macrophages: role of acyl-CoA:cholesterol acyltransferase. EMBO J. 1985 Nov;4(11):2773–2779. doi: 10.1002/j.1460-2075.1985.tb04003.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Schmitz G., Wulf G., Brüning T., Assmann G. Flow-cytometric determination of high-density-lipoprotein binding sites on human leukocytes. Clin Chem. 1987 Dec;33(12):2195–2203. [PubMed] [Google Scholar]
  45. Schonfeld G. The genetic dyslipoproteinemias--nosology update 1990. Atherosclerosis. 1990 Mar;81(2):81–93. doi: 10.1016/0021-9150(90)90014-a. [DOI] [PubMed] [Google Scholar]
  46. Seilhamer J. J., Protter A. A., Frossard P., Levy-Wilson B. Isolation and DNA sequence of full-length cDNA and of the entire gene for human apolipoprotein AI--discovery of a new genetic polymorphism in the apo AI gene. DNA. 1984 Aug;3(4):309–317. doi: 10.1089/dna.1.1984.3.309. [DOI] [PubMed] [Google Scholar]
  47. Seishima M., Noma A., Torizawa H., Muto Y. Changes of serum apolipoprotein levels after oral administration of fat in human subjects. Atherosclerosis. 1988 Sep;73(1):39–43. doi: 10.1016/0021-9150(88)90161-x. [DOI] [PubMed] [Google Scholar]
  48. Stampfer M. J., Sacks F. M., Salvini S., Willett W. C., Hennekens C. H. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991 Aug 8;325(6):373–381. doi: 10.1056/NEJM199108083250601. [DOI] [PubMed] [Google Scholar]
  49. Steyrer E., Kostner G. M. Activation of lecithin-cholesterol acyltransferase by apolipoprotein D: comparison of proteoliposomes containing apolipoprotein D, A-I or C-I. Biochim Biophys Acta. 1988 Feb 19;958(3):484–491. doi: 10.1016/0005-2760(88)90235-4. [DOI] [PubMed] [Google Scholar]
  50. Tall A. R. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest. 1990 Aug;86(2):379–384. doi: 10.1172/JCI114722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Weisgraber K. H., Mahley R. W., Kowal R. C., Herz J., Goldstein J. L., Brown M. S. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein. J Biol Chem. 1990 Dec 25;265(36):22453–22459. [PubMed] [Google Scholar]
  52. Windler E., Havel R. J. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J Lipid Res. 1985 May;26(5):556–565. [PubMed] [Google Scholar]
  53. Yamashita S., Sprecher D. L., Sakai N., Matsuzawa Y., Tarui S., Hui D. Y. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J Clin Invest. 1990 Sep;86(3):688–695. doi: 10.1172/JCI114764. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES